Self-delivering THPC-modified cytochrome c induces cancer cell apoptosis
Zipei Tan1, Tao Jiang1, Zirun Wang1
1Key Laboratory of Precision and Intelligent Chemistry, Department of Chemistry, University of Science and Technology of China, Hefei, Anhui 230026, China. mma@ustc.edu.cn.
None:
THPC modification converts cytochrome c into a self-delivering anticancer protein. The conjugate escapes endosomal degradation in a manner dependent on endolysosomal acidification, activates caspase-9/3, and induces apoptosis in cancer cells. This work offers a simple, carrier-free strategy for cytosolic protein therapeutics.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Extrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...


